Dr. Kolb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Rockland Rd
Wilmington, DE 19803Phone+1 302-651-4000Fax+1 302-651-5510
Summary
- Dr. Edward Anders Kolb is a pediatric hematologist/oncologist in Wilmington, DE and is affiliated with Alfred I. duPont Hospital for Children. He received his medical degree from Sidney Kimmel Medical College and has been in practice 20 years. He is experienced in primary immunodeficiency diseases, lymphoid leukemia, chronic myelogenous leukemia, graft-versus-host disease, and pharmacology.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1999 - 2002
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1996 - 1999
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996
- University of PennsylvaniaBA, Biological Basis of Behavior, 1988 - 1992
Certifications & Licensure
- DE State Medical License 2007 - 2025
- PA State Medical License 2015 - 2024
- FL State Medical License 2015 - 2023
- NJ State Medical License 2015 - 2017
- NY State Medical License 1999 - 2009
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctors Philadelphia Magazine, 2016
- Researcher of the Year Nemours/Alfred I duPont Hospital for Children, 2015
- Top Doctors Delaware Today, 2014
- Join now to see all
Publications & Presentations
PubMed
- Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.Valerie B Sampson, Nancy S Vetter, Wendong Zhang, Pratima U Patil, Robert W Mason
Oncotarget. 2024-10-11 - Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the internatio...Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan
Leukemia. 2024-10-01 - 1 citationsCD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.Andrew J Menssen, Chad A Hudson, Todd Alonzo, Robert Gerbing, Laura Pardo
Haematologica. 2024-10-01
Journal Articles
- Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisMurphy B, Yin H, Maris JM, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Keir ST, Kurmasheva RT, Dvorchik I, Wu J, Billups CA, Boateng N, Smith MA, Lock RB, Houghton PJ, Cancer Res, 1/1/2016
- Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing programSmith MA, Gorlick R, Kolb EA, Lock R, Carol H, Maris JM, Keir ST, Morton CL, Reynolds CP, Kang MH, Arts J, Bashir T, Janicot M, Kurmasheva RT, Houghton PJ, Pediatr Blood Cancer, 1/1/2012
- Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programHoughton PJ, Gorlick R, Kolb EA, Lock R, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Phelps D, Maris JM, Billups C, Smith MA, Pediatr Blood Cancer, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia _ a COG and Tpaml StudyEdward Anders Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a ChildrenÍs Onc...Anders E. Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase 1/2 Study of Quizartinib (Q) in Combination with Re-Induction Chemotherapy and As Single-Agent Continuation Therapy in Pediatric and Young Adult Patients with ...Edward Anders Kolb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML05312018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Career-Development Lunch Sessions: Pediatric Clinical Malignant Hematology/BMT60th American Society of Hematology Annual Meeting - 12/1/2018
- Join now to see all
Other
- Hematopoietic Stem Cell TransplantationPowell JL, Hingorani P, Grupp SA, Kolb EA, eMedicine from WebMD
http://emedicine.medscape.com/article/991032-overview
1/11/2009 - Familial Mosaic Monosomy 7 SyndromeMorrissette JJD, de Chadarevian JP, Kolb EA, GeneReviews
http://www.ncbi.nlm.nih.gov/books/NBK45015/
University of Washington, Seattle - 1/8./2010
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: